It was proved that TLR2 ablation in mice with obesity decreases adipose tissue metaflammation and improves glucose tolerance, promoting TLR2 as a therapy target to prevent subsequent complications18. Here, TLR2 is linked to obesity due to melanocortin 4 receptor deficiency.